Navigation Links
ExonHit Therapeutics - 2007 Financial Results
Date:3/5/2008

PARIS, March 5 /PRNewswire-FirstCall/ -- ExonHit Therapeutics S.A., a French drug and diagnostic discovery company, today announces its consolidated financial results for the year ending December 31, 2007.

2007 Key Events

- Milestone reached in the therapeutic research collaboration with Allergan Inc., (NYSE: AGN) in view of the initiation of Phase 1 trials with the first compound resulting from the collaboration;

- Approval by the AFSSAPS (Agence Francaise de Securite Sanitaire des Produits de Sante) and by ethics committees to initiate a clinical trial on 135 patients suffering from Alzheimer's disease, as a result of Phase 1 clinical trials of EHT0202 which were successfully realized during the year;

- Prototype of the first blood test of Alzheimer's Disease which the Company wishes to sell, as a first commercial step and as early as 2009, in its service laboratories which are GLPS (Good Laboratory Practices Standards) compliant, to the pharmaceutical industry;

- Signature of an amendment to the strategic partnership with bioMerieux in the field of cancer diagnostics. Pursuant to this amendment, ExonHit obtained certain commercial rights to diagnostic tools resulting from the collaboration and bioMerieux will have more flexibility to initiate new R&D programs in this field;

- New genomic map for the analysis of the murine genome;

- Increased financial resources, substantial improvement of stock liquidity and higher free float.
Other 2007 important events

- Key financial figures

- Total revenues at EUR 5.4 million in 2007 (EUR 5.6 million in 2006);

- R&D expenses at EUR 8.6 million in 2007 (EUR 6.8 million in 2006);

- Operating loss at EUR 7.8 million in
'/>"/>

SOURCE ExonHit Therapeutics SA
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related biology technology :

1. ExonHit Therapeutics: Allergan and ExonHits First Collaboration Compound to Begin Human Clinical Trials
2. ExonHit Completes a Prototype to Detect Alzheimers Disease From Blood
3. ExonHit Gets Regulatory Approval to Initiate a Phase 2 Clinical Trial for EHT 0202 in Alzheimers Disease
4. ExonHit and bioMerieux Amend Their Strategic Partnership
5. ExonHit Builds A New Organisation
6. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
7. DJO Incorporateds Pending Merger With ReAble Therapeutics Clears U.S. Antitrust Review
8. PeriCor Therapeutics Announces Closing of Licensing Agreement for Acadesine with Schering-Plough Corporation
9. Systems Medicine (SM), a Subsidiary of Cell Therapeutics, Inc. (CTI), Announces Execution of CRADA with NCI/NIH to Develop Potential Cancer Treatments Targeting the Insulin Growth Factor (IGF) Pathway
10. Amsterdam Molecular Therapeutics to Release H1 2007 Results on August 29, 2007
11. Nektar Therapeutics Appoints Tim Harkness as Chief Financial Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... 23, 2014 This is a ... of the Phenolic Resin industry in Global and ... industry, including definitions, applications and industry chain structure. ... are provided with a focus on history, developments, ... comparison between the international and Chinese situation is ...
(Date:9/23/2014)... de Reuil, France (PRWEB) September 23, 2014 ... to protection of laboratory personnel since 1968 and Burdinola, ... the development of a new filtered fume hood. ... above their laboratory fume hood, Burdinola will now offer ... for filtering a wide range of chemicals, best-in-class detection ...
(Date:9/23/2014)... Proove Biosciences , the commercial and research ... the association between specific genes and patients’ predisposition to ... Health Congress’ 27th Annual Scientific Program in Orlando, ... of ‘Embracing Change.’ Mental health, and healthcare as a ... challenges presented by the Affordable Care Act to the ...
(Date:9/23/2014)... Sept. 23, 2014 Research and ... "Proteomics Markets for Research and IVD Applications (Mass ... report to their offering. This ... applications, both in their research use and in ... the study of the structure and function of ...
Breaking Biology Technology:Phenolic Resin Industry (International, China) Development Policy and Plan Now Available at ReportsnReports.com 2Erlab Partners with Burdinola to Deliver an Innovative Filtered Fume Hood 2Proove Biosciences Will Be Exhibiting New Genetic Research at the 27th Annual US Psych Congress Scientific Program 2Proove Biosciences Will Be Exhibiting New Genetic Research at the 27th Annual US Psych Congress Scientific Program 3Proteomics Markets for Research and IVD Applications (Mass Spectrometry, Chromatography, Microarrays, Electrophoresis, Immunoassays, Other Technologies) 2Proteomics Markets for Research and IVD Applications (Mass Spectrometry, Chromatography, Microarrays, Electrophoresis, Immunoassays, Other Technologies) 3Proteomics Markets for Research and IVD Applications (Mass Spectrometry, Chromatography, Microarrays, Electrophoresis, Immunoassays, Other Technologies) 4
... The power to edit genes is as revolutionary, immediately ... Gutenberg,s printing press. And like Gutenberg,s invention, most DNA ... brilliant technology in its infancy. Now, Harvard researchers developing ... processing have rewritten the genome of living cells using ...
... Neogen Corporation (NASDAQ: NEOG ) announces ... , Tuesday, July 26, 2011 @ 11:00 ETWhere: , ... -- Simply log on to the web at the ... Corporation, +1-800-234-5333If you are unable to participate during the ...
... time that the hormone leptin acts in the brain to ... mystery. Now, new research published by Cell Press in the ... neurobiological mechanisms that may underlie the antiobesity effects of leptin. ... cells and acts at its receptor in the brain to ...
Cached Biology Technology:Editing the genome 2Editing the genome 3Modulation of inhibitory output is key function of antiobesity hormone 2
(Date:9/23/2014)... more carbon than the atmosphere and small changes ... effect on atmospheric greenhouse gas concentrations. A new ... concludes that climate warming does not accelerate ... storage, despite increases in ecosystem productivity. , ... Ecologist Dr. Christian Giardina, with the agency,s Institute ...
(Date:9/23/2014)... funds to support the next phase of its Tissue ... predicting drug safety and effectiveness. Researchers will collaborate over ... and combine them into an integrated system that can ... by the National Center for Advancing Translational Sciences (NCATS), ... in 2014 with additional support over the remaining two ...
(Date:9/23/2014)... tissues during the healing process, cells must be ... scientists believed this communication happened primarily through chemical ... the University of Pittsburgh have found that another ... not more crucial. The findings, published in this ... National Academy of Sciences , could lead to ...
Breaking Biology News(10 mins):Study helps assess impact of temperature on belowground soil decomposition 2NIH funds next phase of Tissue Chip for Drug Screening program 2NIH funds next phase of Tissue Chip for Drug Screening program 3NIH funds next phase of Tissue Chip for Drug Screening program 4The mechanics of tissue growth 2
... 20 years have suggested (though not unequivocally,confirmed) that semen ... sperm counts and,reduced sperm motility.(1) The explanations have been ... and to male smoking. Now, a new study,based on ... study cohorts, suggests that,exposure to several factors in utero ...
... with thinner roots can grow deeper, a trait which could ... New research, to be presented at the Society for Experimental ... have fewer cortical cells in the outer layer of their ... A research team headed by Prof Jonathan Lynch at the ...
... in Antarctica, is so dark, deep and cold that scientists ... place where nothing could live. However, work by Dr. ... sciences, and his colleagues has revealed a surprising variety of ... environments. A paper published June 26 in PLOS ONE ...
Cached Biology News:Early life and in utero factors found to influence testicular function in adulthood 2Early life and in utero factors found to influence testicular function in adulthood 3In subglacial lake, surprising life goes on 2In subglacial lake, surprising life goes on 3In subglacial lake, surprising life goes on 4In subglacial lake, surprising life goes on 5
Recombinant DNA polymerase from Thermus aquaticus expressed in E. coli; 5 units/L; 1 tube of 1, 000 units enzyme/tube w/Buffer II and MgCl2...
... - 5 units/µL ,• High specific activity ... Leaves an 'A' overhang ,• Processes ... very high activity in primer extension and ... quality of the enzyme, each lot has ...
Recombinant DNA polymerase from Thermus aquaticus expressed in E. coli; 5 units/uL; 25 tubes of 1, 000 units enzyme/tube w/ Buffer I...
... Gold® DNA Polymerase is a chemically modified ... chemical moiety is attached to the enzyme, ... the first ramp of thermal cycling (when ... temperatures), the enzyme is inactive. The result ...
Biology Products: